Pharma Companies Pharmaceuticals Synthetic Chemistry 
DrugBaron
FEBRUARY 7, 2022
That’s the part of the process that’s analgous to the library evolution phase of Galaxy The classical approach beloved of large pharma companies is really a brute-force method: make as many molecules as you can to assemble the SAR.
Drug Target Review
JANUARY 19, 2024
I worked on a project that required development of a highly sensitive method and analysis of an active pharmaceutical ingredient to determine accurate levels of two potential genotoxic impurities. We are responsible for formulating a long-term strategy for addressing nitrosamine impurities in pharmaceuticals.
Expert insights. Personalized for you.
100 
Let's personalize your content